CYP2E1 and risk of chemically mediated cancers

Author： Trafalis Dimitrios T Panteli Eleftheria S Grivas Anastasios Tsigris Christos Karamanakos Petros N

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.6, Iss.3, 2010-03, pp. : 307-319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CYP2E1 polymorphisms and gene––environment interactions in the risk of upper aerodigestive tract cancers among Indians

By Soya S S Vinod T Reddy K S Gopalakrishnan S Adithan C

Pharmacogenomics, Vol. 9, Iss. 5, 2008-05 ,pp. : 551-560

Future Medicine

Access to resources Recommend Favorite

CYTOCHROME P-450-MEDIATED DIFFERENTIAL OXIDATIVE MODIFICATION OF PROTEINS: ALBUMIN, APOLIPOPROTEIN E, AND CYP2E1 AS TARGETS

By Choi Dal Leininger-Muller Brigitte Wellman Maria Kim Young Siest Gerard

Journal of Toxicology and Environmental Health, Vol. 67, Iss. 23-24, 2004-12 ,pp. : 2061-2071

Taylor & Francis Ltd

Access to resources Recommend Favorite

Molecular Dynamics Simulations of CYP2E1

Medicinal Chemistry, Vol. 8, Iss. 2, 2012-03 ,pp. : 208-221

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Polymorphism in CYP2E1: Population Distribution of CYP2E1 Activity

By Neafsey Pat

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 362-388

Taylor & Francis Ltd

Access to resources Recommend Favorite

Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers

Current Cancer Drug Targets, Vol. 16, Iss. 1, 2016-01 ,pp. : 71-78

Bentham Science Publishers

Access to resources Recommend Favorite